Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

PHASE2CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

September 2, 2009

Primary Completion Date

March 6, 2012

Study Completion Date

May 10, 2013

Conditions
Fracture Healing
Interventions
BIOLOGICAL

Romosozumab

Administered by subcutaneous injection

DRUG

Placebo

Administered by subcutaneous injection

Trial Locations (103)

1004

Research Site, Riga

1005

Research Site, Riga

1081

Research Site, Budapest

1527

Research Site, Sofia

2226

Research Site, Kongsvinger

2400

Research Site, København NV

2650

Research Site, Hvidovre

2700

Research Site, Blagoevgrad

3050

Research Site, Parkville

3143

Research Site, Tauranga

3220

Research Site, Geelong

3400

Research Site, Liepāja

3526

Research Site, Miskolc

4002

Research Site, Plovdiv

4201

Research Site, Valmiera

4400

Research Site, Nyíregyháza

5800

Research Site, Pleven

6725

Research Site, Szeged

7000

Research Site, Rousse

8000

Research Site, Ã…rhus C

8022

Research Site, Christchurch

11220

Research Site, Brooklyn

11312

Research Site, Tallinn

12462

Research Site, Athens

13009

Research Site, Marseille

14561

Research Site, Athens

14642

Research Site, Rochester

16602

Research Site, Altoona

19104

Research Site, Philadelphia

20122

Research Site, Milan

20142

Research Site, Milan

20246

Research Site, Hamburg

26500

Research Site, Pátrai

29203

Research Site, Columbia

30625

Research Site, Hanover

32209

Research Site, Jacksonville

35294

Research Site, Birmingham

37126

Research Site, Verona

41110

Research Site, Larissa

44035

Research Site, Nantes

44320

Research Site, Kaunas

46202

Research Site, Indianapolis

48149

Research Site, Münster

48202

Research Site, Detroit

50139

Research Site, Florence

50410

Research Site, Tartu

52074

Research Site, Aachen

56126

Research Site, Pisa

56429

Research Site, Thessaloniki

59000

Research Site, Lille

63110

Research Site, St Louis

64040

Research Site, Monterrey

68165

Research Site, Mannheim

75571

Research Site, Paris

80012

Research Site, Aurora

80204

Research Site, Denver

84070

Research Site, Sandy City

92868

Research Site, Orange

115280

Research Site, Moscow

117292

Research Site, Moscow

119049

Research Site, Moscow

127299

Research Site, Moscow

129327

Research Site, Moscow

150003

Research Site, Yaroslavl

196247

Research Site, Saint Petersburg

300736

Research Site, Timișoara

T4N 6V7

Research Site, Red Deer

L1S 2J5

Research Site, Ajax

P7B 7C7

Research Site, Thunder Bay

M5C 1R6

Research Site, Toronto

N2J 1C4

Research Site, Waterloo

N9A 1E1

Research Site, Windsor

H3G 1A4

Research Site, Montreal

H4J 1C5

Research Site, Montreal

Unknown

Research Site, Hong Kong

Research Site, New Territories

560 034

Research Site, Bangalore

560 054

Research Site, Bangalore

575 002

Research Site, Mangalore

411 005

Research Site, Pune

302 022

Research Site, Jaipur

625 020

Research Site, Madurai

382 428

Research Site, Gandhinagar

575 001

Research Site, Mangalore

422 009

Research Site, Nashik

00133

Research Site, Roma (RM)

04130

Research Site, Vilnius

15-276

Research Site, Bialystok

41-902

Research Site, Bytom

31-826

Research Site, Kraków

30-901

Research Site, Krakow

20-718

Research Site, Lublin

014461

Research Site, Bucharest

050098

Research Site, Bucharest

833 05

Research Site, Bratislava

950 01

Research Site, Nitra

921 01

Research Site, Piešťany

LS1 3EX

Research Site, Leeds

E1 1BB

Research Site, London

NE1 4LP

Research Site, Newcastle

NR4 7UY

Research Site, Norwich

OX3 9DU

Research Site, Oxford

HA7 4LP

Research Site, Stanmore

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Amgen

INDUSTRY

NCT00907296 - Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing | Biotech Hunter | Biotech Hunter